These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19469393)

  • 1. Is an FDA alert harming patients?
    Schuman E
    JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393
    [No Abstract]   [Full Text] [Related]  

  • 2. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say?
    Kogut SJ
    J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
    Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE
    Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptans and serotonin syndrome.
    Fine A; Bastings E
    Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550
    [No Abstract]   [Full Text] [Related]  

  • 5. Triptans, SSRIs/SNRIs and serotonin syndrome.
    Rothrock JF
    Headache; 2010 Jun; 50(6):1101-2. PubMed ID: 20618824
    [No Abstract]   [Full Text] [Related]  

  • 6. From the editorial office.
    Rothrock JF
    Headache; 2012; 52(7):1069. PubMed ID: 22755549
    [No Abstract]   [Full Text] [Related]  

  • 7. The serotonin syndrome, triptans, and the potential for drug-drug interactions.
    Shapiro RE; Tepper SJ
    Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.
    Evans RW
    MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptans and serotonin syndrome.
    Evans RW
    Cephalalgia; 2008 May; 28(5):573-4; author reply 574-5. PubMed ID: 18355351
    [No Abstract]   [Full Text] [Related]  

  • 10. Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessary.
    Horn JR; Hansten PD
    J Manag Care Pharm; 2011 Nov; 17(9):713. PubMed ID: 22050397
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?
    Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A
    J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
    Bonetto N; Santelli L; Battistin L; Cagnin A
    Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
    Orlova Y; Rizzoli P; Loder E
    JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions with triptans : which are clinically significant?
    Rolan PE
    CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin syndrome and the use of SSRIs.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2004 Feb; 42(2):16-20. PubMed ID: 14982105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptan migraine treatments and antidepressants: risk of serotonin syndrome.
    Wooltorton E
    CMAJ; 2006 Oct; 175(8):874. PubMed ID: 16988028
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin toxicity revisited.
    Schuman E
    Headache; 2009 May; 49(5):784-5. PubMed ID: 19456889
    [No Abstract]   [Full Text] [Related]  

  • 18. Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.
    Boutilier AS; Gardner DM
    J Clin Pharm Ther; 2003 Feb; 28(1):69-72. PubMed ID: 12605621
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serotonergic syndrome. Serotonergic syndrome caused by paroxetine].
    Hilberg T; Mørland J
    Tidsskr Nor Laegeforen; 1999 Apr; 119(11):1646-7. PubMed ID: 10385811
    [No Abstract]   [Full Text] [Related]  

  • 20. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome?
    Evans RW
    Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.